Ticker
KROSCompany Name
KEROS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Goodwill and Intangibles | Goodwill & Intangibles to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 757.16M | $ 0 | 0% |
3/31/2025 | $ 784.56M | $ 0 | 0% |
12/31/2024 | $ 615.89M | $ 0 | 0% |
9/30/2024 | $ 579.27M | $ 0 | 0% |
6/30/2024 | $ 455.02M | $ 0 | 0% |
3/31/2024 | $ 485.82M | $ 0 | 0% |
12/31/2023 | $ 370.02M | $ 0 | 0% |
9/30/2023 | $ 326.25M | $ 0 | 0% |
6/30/2023 | $ 356.31M | $ 0 | 0% |
3/31/2023 | $ 384.44M | $ 0 | 0% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Intangibles / Assets
(=) Intang. to Assets
Intang. to Assets for KEROS THERAPEUTICS INC is calculated as follows: Intangibles [ $ 0 ] / Assets [ $ 138.25M ]
(=) Intang. to Assets [ 0% ]
Minimum
Sep 30, 2020
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.24K |
---|---|
min | 0% |
max | 23.16% |
average | 3.98% |
median | 0.52% |
std | 6.09% |